(Q42546661)

2 November 2017

title

Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal (English)

1 reference

2 November 2017

Lin SK

1

1 reference

2 November 2017

Strang J

2

1 reference

2 November 2017

Su LW

3

1 reference

2 November 2017

Tsai CJ

4

1 reference

2 November 2017

Hu WH

5

1 reference

2 November 2017

publication date

1 November 1997

1 reference

Drug and Alcohol Dependence

2 November 2017

published in

1 reference

2 November 2017

volume

48

1 reference

2 November 2017

issue

2

1 reference

2 November 2017

page(s)

127-133

1 reference

Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Another trial that failed

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

The Atwood Hall Health Promotion Program, Federal Medical Center, Lexington, KY. Effects on drug-involved federal offenders

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Clonidine blocks acute opiate-withdrawal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Opiate detoxification with lofexidine

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Clonidine and the treatment of the opiate withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Opiate withdrawal symptoms in response to 10-day and 21-day methadone withdrawal programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Effects of information on the opiate withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Clonidine in morphine withdrawal. Differential effects on signs and symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Clonidine versus long- and short-term methadone-aided withdrawal from opiates. An uncontrolled comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Clonidine in outpatient detoxification from methadone maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Clonidine and naltrexone in the outpatient treatment of heroin withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Physiological parameters of morphine dependence in man—Tolerance, early abstinence, protracted abstinence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Effectiveness of lofexidine in blocking morphine-withdrawal signs in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Comparison of linear versus inverse exponential methadone reduction curves in the detoxification of opiate addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Effects of clonidine on morphine withdrawal signs in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Clonidine in opiate withdrawal: review and appraisal of clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

Lofexidine and clonidine in moderate essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2897%2900116-6

7 January 2021

10.1016/S0376-8716(97)00116-6

Identifiers

DOI

1 reference

2 November 2017

1 reference